Barclays raised the firm’s price target on MetLife (MET) to $94 from $88 and keeps an Overweight rating on the shares as part of a Q2 earnings preview for the North America life insurance group. The firm says equity market strength has lifted long-term earnings and results in upward revisions to its 2026-2027 estimates. It recommends exposure to names with equity leverage and capital flexibility. Barclays highlights Jackson Financial (JXN) as a key Overweight.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MET:
- Ameriprise price target raised to $434 from $423 at Piper Sandler
- Brighthouse Financial price target lowered to $55 from $63 at Piper Sandler
- MetLife Announces $10 Billion Reinsurance Deal with Chariot
- MetLife sees Q2 variable investment income $175M-$225M pre-tax
- MetLife Releases Preliminary Q2 2025 Investment Income Estimates